SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16285330
Source:
http://linkedlifedata.com/resource/pubmed/id/16285330
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0022067
,
umls-concept:C0033105
,
umls-concept:C0151744
,
umls-concept:C0278329
,
umls-concept:C0392747
,
umls-concept:C0443172
pubmed:issue
3
pubmed:dateCreated
2005-11-15
pubmed:abstractText
Secondary prevention therapies, such as angiotension converting enzyme (ACE) inhibitors, beta-blockers and statins, are known to reduce cardiovascular morbidity and mortality.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7806864
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...
pubmed:status
MEDLINE
pubmed:issn
0021-1265
pubmed:author
pubmed-author:BennettKK
,
pubmed-author:FeelyJJ
,
pubmed-author:GOLDJ KJK
,
pubmed-author:JohnsonHH
,
pubmed-author:ShelleyEE
pubmed:issnType
Print
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16285330-Adrenergic beta-Antagonists
,
pubmed-meshheading:16285330-Adult
,
pubmed-meshheading:16285330-Aged
,
pubmed-meshheading:16285330-Angiotensin-Converting Enzyme Inhibitors
,
pubmed-meshheading:16285330-Antihypertensive Agents
,
pubmed-meshheading:16285330-Aspirin
,
pubmed-meshheading:16285330-Drug Therapy, Combination
,
pubmed-meshheading:16285330-Drug Utilization
,
pubmed-meshheading:16285330-Evidence-Based Medicine
,
pubmed-meshheading:16285330-Female
,
pubmed-meshheading:16285330-Humans
,
pubmed-meshheading:16285330-Hydroxymethylglutaryl-CoA Reductase Inhibitors
,
pubmed-meshheading:16285330-Ireland
,
pubmed-meshheading:16285330-Male
,
pubmed-meshheading:16285330-Middle Aged
,
pubmed-meshheading:16285330-Myocardial Ischemia
,
pubmed-meshheading:16285330-Physician's Practice Patterns
,
pubmed-meshheading:16285330-Prevalence
,
pubmed-meshheading:16285330-Retrospective Studies
,
pubmed-meshheading:16285330-Treatment Outcome
pubmed:articleTitle
Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.
pubmed:affiliation
Dept of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8. bennettk@tcd.ie
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't